Back to Search Start Over

Assessing measles vaccine failure in Tianjin, China.

Authors :
Masters NB
Wagner AL
Ding Y
Zhang Y
Boulton ML
Source :
Vaccine [Vaccine] 2019 May 31; Vol. 37 (25), pp. 3251-3254. Date of Electronic Publication: 2019 May 08.
Publication Year :
2019

Abstract

Despite increasing global measles vaccination coverage, progress toward measles elimination has slowed in recent years. In China, children receive a measles-containing vaccine (MCV) at 8 months, 18-24 months, and some urban areas offer a third dose at age 4-6 years. However, substantial measles cases in Tianjin, China, occur among individuals who have received multiple MCV doses. This study describes the vaccination history of measles cases 8 months - 19 years old. Data came from measles cases in Tianjin's reportable disease surveillance system (2009-2013), and from a case control study (2011-2015). Twenty-nine percent of those in the surveillance dataset and 54.4% of those in the case series received at least one dose of MCV. The minimum and median time-to-diagnosis since vaccination revealed an increase in time since vaccination for incremental doses. Considerable measles cases in Tianjin occur in vaccinated children, and further research is needed to understand the reasons for vaccine failure.<br /> (Copyright © 2019 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1873-2518
Volume :
37
Issue :
25
Database :
MEDLINE
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
31078327
Full Text :
https://doi.org/10.1016/j.vaccine.2019.05.005